U.S. FDA considering lowering recommended age for Pfizer/BioNTech COVID-19 boosters
Go back to U.S. FDA considering lowering recommended age for Pfizer/BioNTech COVID-19 boosters| (NASDAQ: BNTX) | Delayed: 113.12 +20.37 (21.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.75 | 52 Week High | $ | |||
| Open | $109.29 | 52 Week Low | $ | |||
| Day High | $116.00 | P/E | N/A | |||
| Day Low | $107.18 | EPS | $ | |||
| Volume | 8,777,366 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.24 +0.99 (3.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.25 | 52 Week High | $37.39 | |||
| Open | $27.60 | 52 Week Low | $28.25 | |||
| Day High | $28.44 | P/E | 17.12 | |||
| Day Low | $27.58 | EPS | $1.65 | |||
| Volume | 59,758,239 | |||||
